semaglutide supply shortage news november 2025 Limited' of weight loss drug launched in UK GLP-1 Pipeline Update: November 2025

This is especially useful after meals or when the taste feels stronger during the day

It is based on the active ingredient semaglutide, a GLP-1 receptor agonist, which helps lower blood glucose levels through various mechanisms, including stimulating insulin secretion and inhibiting glucagon release

This higher-concentration option provides the most medication per vial and works well for patients on higher tirzepatide doses

It is supplied for laboratory workflows as a solvent and diluent, specified for controlled use where sterility and consistency are required

Don't miss any updates on Setria and other Kyowa Hakko innovations